Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nadia M. Krasner
Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation Through a Calcium and AMPK Dependent Mechanism
PLoS ONE
Multidisciplinary
Related publications
A Glucagon-Like Peptide-1 Analog, Liraglutide, Ameliorates Endothelial Dysfunction Through miRNAs to Inhibit Apoptosis in Rats
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
A Mechanism for Agonist Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor Through Modelling & Molecular Dynamics
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)
Science-Business eXchange
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
The Glucagon-Like Peptide-1 Analog Liraglutide Suppresses Ghrelin and Controls Diabetes in a Patient With Prader-Willi Syndrome
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Upregulation of Alpha Cell Glucagon-Like Peptide 1 (GLP-1) in Psammomys Obesus—an Adaptive Response to Hyperglycaemia?
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 (GLP-1) Gene Therapy for Diabetes
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
A GLP-1 Receptor Agonist Liraglutide Inhibits Endothelial Cell Dysfunction and Vascular Adhesion Molecule Expression in an ApoE-/- Mouse Model
Diabetes and Vascular Disease Research
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Glucagon-Like Peptide-1 and Satiety
Nature
Multidisciplinary
